Home » Topics » Medical technology

Medical technology
RSS

Peptech Reinvents Itself As Arana, Shifts To Antibodies

Nov. 14, 2007

Actelion Advances Clazosentan Into Phase III Vasospasm Study

Nov. 14, 2007

By Cormac Sheridan

Novel Obesity Gene Plays A Role In Modifying DNA

Nov. 14, 2007

By Sharon Kingman

Acambis Partners West Nile Vaccine In $80M Sanofi Deal

Nov. 14, 2007

Clinic Roundup

Nov. 14, 2007

Other News To Note

Nov. 14, 2007

VaxGen, Raven Get 'Fresh Start' Via Merger To Focus On Cancer

Nov. 14, 2007

AVAX Starts Pivotal Testing With M-Vax Cancer Vaccine

Nov. 14, 2007

Smoke Clears; Pfizer Paying Nektar $135M In Exubera Deal

Nov. 14, 2007

Acambis Partners West Nile Vaccine In $80M Sanofi Deal

Nov. 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.